---
schema_version: "secwatch.filing_event.v1"
accession: "0001625297-25-000025"
form_type: "8-K"
ticker: "INDV"
cik: "0001625297"
company_name: "Indivior Pharmaceuticals, Inc."
filed_at: "2025-03-27T23:59:59+00:00"
generated_at: "2026-05-24T03:56:01.837795+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Indivisor names Joe Ciaffoni CEO; proposes incentive plan with share price targets up to $35

## Summary
- Joe Ciaffoni to become CEO effective upon shareholder approval of new Directors' Remuneration Policy at May 8, 2025 AGM.
- On-hire PSU award up to 1.575M shares vests based on VWAP targets: $15, $20, $25, $30, $35 over 1–5 years.
- On-hire RSU award of 525,000 shares with cliff vest on 3rd anniversary of start date.
- Proposed policy increases LTIP on-target grant to 400% of salary in 2026 and 700% in 2027.
- Benchmarked vs US biopharma peers; CEO's potential dilution <2% of value created for shareholders.

## SEC filing metadata
- accession: 0001625297-25-000025
- form_type: 8-K
- ticker: INDV
- cik: 0001625297
- company_name: Indivior Pharmaceuticals, Inc.
- filed_at: 2025-03-27T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.75
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1625297/000162529725000025/0001625297-25-000025-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1625297/000162529725000025/indv-20250327.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001625297-25-000025
- JSON: https://secwatch.observer/filing/0001625297-25-000025.json
- Plain text: https://secwatch.observer/filing/0001625297-25-000025.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.